Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

PROSHARES TRUST (ZBIO) EPS (Weighted Average and Diluted): 2023-2025

Historic EPS (Weighted Average and Diluted) for Zenas BioPharma (ZBIO) over the last 2 years, with Sep 2025 value amounting to -$1.22.

  • Zenas BioPharma's EPS (Weighted Average and Diluted) rose 75.70% to -$1.22 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.67, marking a year-over-year increase of 121.64%. This contributed to the annual value of -$11.89 for FY2024, which is 50.97% up from last year.
  • Zenas BioPharma's EPS (Weighted Average and Diluted) amounted to -$1.22 in Q3 2025, which was up 2.40% from -$1.25 recorded in Q2 2025.
  • Zenas BioPharma's EPS (Weighted Average and Diluted)'s 5-year high stood at $16.94 during Q4 2024, with a 5-year trough of -$24.23 in Q2 2024.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$5.28, with a median of -$1.25 in 2025.
  • Examining YoY changes over the last 5 years, Zenas BioPharma's EPS (Weighted Average and Diluted) showed a top increase of 205.61% in 2024 and a maximum decrease of 356.12% in 2024.
  • Over the past 3 years, Zenas BioPharma's EPS (Weighted Average and Diluted) (Quarterly) stood at -$16.04 in 2023, then spiked by 205.61% to $16.94 in 2024, then spiked by 75.70% to -$1.22 in 2025.
  • Its last three reported values are -$1.22 in Q3 2025, -$1.25 for Q2 2025, and -$0.80 during Q1 2025.